Literature DB >> 13534253

Pathogenesis and significance of post-stenotic dilatation in great vessels.

F ROBICSEK, P W SANGER, F H TAYLOR, R MAGISTRO, E FOTI.   

Abstract

Keywords:  BLOOD VESSELS/pathology

Mesh：

Year:  1958        PMID： 13534253      PMCID： PMC1450702     

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  4 in total

1.  Post-stenotic dilatation of the great vessels.

Authors:  F ROBICSEK
Journal:  Acta Med Scand       Date:  1955

2.  The obscure physiology of poststenotic dilatation; its relation to the development of aneurysms.

Authors:  E HOLMAN
Journal:  J Thorac Surg       Date:  1954-08

3.  Pulmonary circulation in experimental pulmonary stenosis.

Authors:  D HALMAGYI; F ROBICSEK; B FELKAI; J IVANYI; T ZSOTER; Z S SZUCS; M TENYI
Journal:  Acta Med Acad Sci Hung       Date:  1954

4.  [Investigation of the great vessels in congenital cardiac abnormalities].

Authors:  P BIZZA
Journal:  Kiserl Orvostud       Date:  1951
  4 in total
  4 in total

1.  Subclinical coarctation of the aorta.

Authors:  L H EDMUNDS; J E McCLENATHAN; C A HUFNAGEL
Journal:  Ann Surg       Date:  1962-08       Impact factor: 12.969

2.  Localization of congenital stricture of the aorta without contrast radiography.

Authors:  P W SANGER; F ROBICSEK; F H TAYLOR
Journal:  Ann Surg       Date:  1961-03       Impact factor: 12.969

3.  Dilatation of the ascending aorta in patients with congenitally bicuspid aortic valves.

Authors:  F Robicsek; R F Padera; M J Thubrikar
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

4.  Aortic stiffness in aortic stenosis assessed by cardiovascular MRI: a comparison between bicuspid and tricuspid valves.

Authors:  Anvesha Singh; Mark A Horsfield; Soliana Bekele; John P Greenwood; Dana K Dawson; Colin Berry; Kai Hogrefe; Damian J Kelly; John G Houston; Prasad Guntur Ramkumar; Akhlaque Uddin; Toru Suzuki; Gerry P McCann
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.